↓ Skip to main content

Cochrane Database of Systematic Reviews

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

Overview of attention for article published in Cochrane database of systematic reviews, April 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

policy
2 policy sources
twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
248 Dimensions

Readers on

mendeley
372 Mendeley
Title
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Published in
Cochrane database of systematic reviews, April 2008
DOI 10.1002/14651858.cd006739.pub2
Pubmed ID
Authors

Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christian Lerch

Abstract

In type 2 diabetes mellitus there is a progressive loss of beta-cell function. One new approach yielding promising results is the use of the orally active dipeptidyl peptidase-4 (DPP-4) inhibitors like sitagliptin and vildagliptin.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 372 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 5 1%
Singapore 1 <1%
Germany 1 <1%
Spain 1 <1%
Japan 1 <1%
United States 1 <1%
Unknown 362 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 81 22%
Student > Ph. D. Student 45 12%
Student > Bachelor 42 11%
Researcher 40 11%
Student > Postgraduate 31 8%
Other 72 19%
Unknown 61 16%
Readers by discipline Count As %
Medicine and Dentistry 171 46%
Nursing and Health Professions 28 8%
Pharmacology, Toxicology and Pharmaceutical Science 24 6%
Agricultural and Biological Sciences 18 5%
Biochemistry, Genetics and Molecular Biology 12 3%
Other 44 12%
Unknown 75 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2021.
All research outputs
#3,616,924
of 18,917,096 outputs
Outputs from Cochrane database of systematic reviews
#6,165
of 11,891 outputs
Outputs of similar age
#30,732
of 163,857 outputs
Outputs of similar age from Cochrane database of systematic reviews
#47
of 101 outputs
Altmetric has tracked 18,917,096 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,891 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.8. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,857 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.